M1 Kliniken AG (M12) AI Stock Analysis

• Market Cap: €260.37M
• Dividend Yield: 2.8%
• Average Volume (3M): 13.86K
• Price to Earnings (P/E): 6.1
• Beta (1Y): 0.27
• Revenue Growth: 6.52%
• EPS Growth: 7.17%
• Country: DE
• Employees: 219
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 19,643,402
• 10 Day Avg. Volume: 17,849
• 30 Day Avg. Volume: 13,861
• PEG Ratio: 0.32
• Price to Book (P/B): 2.90
• Price to Sales (P/S): 0.91
• P/FCF Ratio: 10.42
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.09
• Revenue Forecast (FY): €371.00M

• Rating: 80 Outperform
• Price Target: €19.00 ▲(4.63% Upside)
• Action: Reiterated Date: 11/26/25
• Date: Action: Reiterated 11/26/25

M1 Kliniken AG earns an overall score of 80, driven primarily by strong financial performance (score: 83, weight: 0.5) with robust revenue and cash flow growth. Positive technical momentum (score: 78, weight: 0.3) further supports the outlook, though valuation (score: 70, weight: 0.2) remains average. The score reflects a solid investment with minor concerns around margin improvement and potential technical pullbacks.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong demand for services and effective market expansion, supporting long-term business sustainability.

Negative Factors

Decreased Total Assets

Declining total assets may signal potential asset divestment or underinvestment, which could impact future growth and operational capacity.

M1 Kliniken AG Business Overview & Revenue Model

Company Description

M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty ...

Read more

M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty ...

How the Company Makes Money

M1 Kliniken AG generates revenue primarily through the provision of aesthetic medical services, including surgical and non-surgical treatments. Key revenue streams include fees for cosmetic procedures, consultations, and follow-up care. The compan...

Read more

M1 Kliniken AG generates revenue primarily through the provision of aesthetic medical services, including surgical and non-surgical treatments. Key revenue streams include fees for cosmetic procedures, consultations, and follow-up care. The compan...

M1 Kliniken AG Financial Statement Overview

Breakdown	TTM	Mar 2025	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	354.98M	339.18M	316.32M	285.29M	314.61M	159.59M
Gross Profit	42.64M	63.60M	32.47M	21.72M	26.06M	13.61M
EBITDA	35.21M	33.44M	21.79M	16.07M	19.78M	10.59M
Net Income	17.74M	16.02M	10.27M	4.32M	8.91M	6.82M
Balance Sheet
Total Assets	203.28M	187.87M	212.95M	197.02M	198.11M	188.74M
Cash, Cash Equivalents and Short-Term Investments	45.67M	23.69M	22.76M	47.50M	49.12M	34.14M
Total Debt	21.82M	10.42M	17.04M	19.67M	30.93M	39.09M
Total Liabilities	56.26M	53.65M	69.73M	53.97M	58.21M	73.42M
Stockholders Equity	118.00M	106.10M	113.25M	95.52M	95.03M	85.75M
Cash Flow
Free Cash Flow	34.46M	29.55M	6.80M	19.25M	14.32M	7.93M
Operating Cash Flow	34.70M	30.55M	7.81M	21.02M	15.66M	9.38M
Investing Cash Flow	5.74M	-5.67M	-9.36M	-1.77M	213.19K	3.12M
Financing Cash Flow	-14.32M	-30.44M	-14.81M	-21.97M	4.03M	377.65K

M1 Kliniken AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 18.16
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:M12, the sentiment is Negative. The current price of 18.16 is above the 20-day moving average (MA) of 15.36, above the 50-day MA of 16.25, and above the 200-day MA of 15.38, indicating a bearish trend. The MACD of -0.57 indicates Positive momentum. The RSI at 35.14 is Neutral, neither overbought nor oversold. The STOCH value of 23.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:M12.

M1 Kliniken AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
M12	80 Outperform	€260.37M	6.07	15.83%	2.80%	6.52%	7.17%
MED	73 Outperform	€171.95M	2.42	15.15%	1.12%	4.90%	―
LIK	73 Outperform	€142.80M	8.54	22.77%	―	0.21%	7.53%
93M1	70 Outperform	€77.71M	-0.27	-47.72%	5.31%	180.19%	-196.45%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
MAK	41 Neutral	€25.37M	-1.84	22.85%	―	6.87%	-94.85%